An interventional study of Motor Data Analysis in Parkinson Disease and Healthy Adult, sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna. Recruiting at 5 sites in Italy. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-02.
Sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna · Not applicable, Interventional, and Device feasibility
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 348 studies in Parkinson Disease with a site in Italy — 89 open to participants now, 108 under way, 4 of them phase 3. Parkinson Disease · Italy.
Among the 348 studies in Parkinson Disease with a site in Italy, this one is the 58th largest by planned enrollment of the 244 interventional ones that give a count, is one of 14 that started in 2024, is one of 146 with no phase, reaches primary completion later than 31 of the 107 other live ones, and was the 302nd registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →89 of the 348 studies in Parkinson Disease with a site in Italy are open now. Recruiting first, the newest first:
Dorian Technologies S.r.l. · Sites in Italy
Ages 18+
University Hospital Tuebingen · Sites in Italy, France, Germany and 4 more countries
Ages 35–80
Newronika · Sites in Italy
Ages 18+
University Hospital of Ferrara · Sites in Italy
Ages 18+
Universita di Verona · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 50 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
348 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 37 · Phase 3 49 · Phase 4 13
First in 2002; this study’s year is marked. 14 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 250 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 82 across the 244 interventional studies, 140 across the 103 observational. Of the 185 that completed or were terminated, 50 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
110 of 348 have an industry lead sponsor. The 10 most frequent:
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna has 1 study filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
24 of the studies in Parkinson Disease with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06657274IRCCS Centro San Giovanni di Dio FatebenefratelliEARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069 | 2026-11-30 |
| NCT07502066IRCCS San Camillo, Venezia, ItalyClinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases | 2026-12 |
| NCT07485218University of Applied Sciences and Arts of Southern SwitzerlandMultidimensional Assessment of Fatigability in Older Adults Living in Southern Switzerland and Elderly With Parkinson's Disease | 2026-12 |
| NCT07637123IRCCS San Raffaele RomaEvaluation of a Soft Elbow Exoskeleton and a Haptic Armband in Post-stroke and Parkinson's Disease Patients | 2026-12 |
| NCT07616050Marta MondelliniEvaluation of the Impact of Virtual Park on Training Motivation in Adult Patients | 2026-12 |
Add all 24 to your calendar (.ics) → With an account.
Among the 348 studies in Parkinson Disease with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy subjects - Inclusion Criteria:
Subjects with Parkinson's disease -- Inclusion criteria:
Exclusion Criteria:
Healthy subjects - Exclusion criteria:
Subjects with Parkinson's disease - Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement
Device: Motor Data Analysis
All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement
Device: Motor Data Analysis
The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.
Number of repetitions
Number of repetitions in Finger Tapping task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Thumb-ForeFinger Tapping task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Opening/Closing task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Pronosupination task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Toe Tapping task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Leg Agility task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Heel Tapping task
Time frame: at Enrollment (T0)
Number of repetitions
Number of repetitions in Heel-Toe Tapping task
Time frame: at Enrollment (T0)
Time to Stand Up
Time to stand up from a chair
Time frame: at Enrollment (T0)
Gait Time
Time to walk for 15 meters straight on
Time frame: at Enrollment (T0)
Rotation Time
Time to perform a turning of 360°
Time frame: at Enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands resting tremor task
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for feet resting tremor task
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands postural tremor task
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands kinetic tremor task
Time frame: At enrollment (T0)
Strides Number
Number of strides to walk for 15 meters straight on
Time frame: at Enrollment (T0)
Plan to share: No
No publications or documents are linked to this record.
Started May 2024 (actual). Primary completion is estimated for Jan 2026, 20 months after the start.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 20 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna